Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Pivot

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancerA Thiery-Vuillemin, E Curtit, T Maurina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2013
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancerJ Cortés, J Baselga, Y-H Im, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2015
Melanoma risk-takers: fathers and sonsF Eisinger, J-F Morère, X Pivot, et al.
International Journal of Medical Sciences|June 21, 2008
Breast cancer screening in France: results of the EDIFICE surveyX Pivot, O Rixe, Jf Morere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearanceM C Etienne, F Leger, X Pivot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trialA Kramar, T Bachelot, N Madrange, et al.
International Journal of Medical Informatics|September 11, 2010
Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errorsV Nerich, S Limat, M Demarchi, et al.
BMC Cancer|November 3, 2019
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancerF Bazan, E Dobi, B Royer, et al.
Oncology|September 28, 2001
Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trialsX Pivot, C Niyikiza, G Poissonnet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemiaX Pivot, E Guardiola, M Etienne, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancerA Thiery-Vuillemin, E Curtit, T Maurina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2013
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancerJ Cortés, J Baselga, Y-H Im, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2015
Melanoma risk-takers: fathers and sonsF Eisinger, J-F Morère, X Pivot, et al.
International Journal of Medical Sciences|June 21, 2008
Breast cancer screening in France: results of the EDIFICE surveyX Pivot, O Rixe, Jf Morere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearanceM C Etienne, F Leger, X Pivot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trialA Kramar, T Bachelot, N Madrange, et al.
International Journal of Medical Informatics|September 11, 2010
Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errorsV Nerich, S Limat, M Demarchi, et al.
BMC Cancer|November 3, 2019
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancerF Bazan, E Dobi, B Royer, et al.
Oncology|September 28, 2001
Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trialsX Pivot, C Niyikiza, G Poissonnet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemiaX Pivot, E Guardiola, M Etienne, et al.
Pageof 10